Cone Health Cancer Center at Alamance Regional is a clinical research site located in Burlington, North Carolina, United States 27215.
Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.
Cone Health Cancer Center at Alamance Regional has participated in 105 clinical trials with 51 currently active.
Therapeutic areas: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7.
Sponsors: National Cancer Institute (NCI), NRG Oncology, SWOG Cancer Research Network.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Burlington
Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cone Health Cancer Center at Alamance Regional has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cone Health Cancer Center at Alamance Regional has 105 clinical trials on record, with 51 currently active. Their work covers Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7.
Cone Health Cancer Center at Alamance Regional has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.